. Author manuscript; available in PMC: 2018 May 17.

Published in final edited form as: Arthritis Rheumatol. 2015 Jun;67(6):1629–1636. doi: 10.1002/art.39104

Table 4.

Outcomes by dose of prednisone used to treat first non-severe relapse

	High-dose prednisone (20mg or greater)	Low-dose prednisone (less than 20mg)	p-value
	N=22	N=22
Mean BVAS/WG at first relapse	2.0 (1.1)	1.4 (0.73)	0.05
Reached remission	17 (77%)	18 (82%)	>0.99
Time to remission (mos)	2.5 (0.5–4.1)	2.5 (1.0–4.4)	0.91
Reached complete remission	8 (36%)	10 (46%)	0.54
Time to complete remission (mos)	6.2 (3.3–12.5)	4.5 (1.9–9.7)	0.31
Outcome at end of follow-up
Non-severe relapse	8 (36.4%)	9 (40.9%)	0.76
Severe relapse	9 (40.9%)	5 (22.7%)	0.20
Time to second relapse (mos)	9.9 (0.7–30.3)	8.7 (1.9–37.2)	0.94